Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anthelminthic Agents

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Rational design of novel organometallic <i>N</i>-acylhydrazones with potent antiparasitic activity on <i>Trypanosoma cruzi</i> and <i>brucei</i>.

Dalton transactions (Cambridge, England : 2003)·2026

Same author

Dissecting the interstrand crosslink DNA repair system of Trypanosoma cruzi.

DNA repair·2023

Same author

Preclinical Studies in Anti-<i>Trypanosomatidae</i> Drug Development.

Pharmaceuticals (Basel, Switzerland)·2021

Same author

Unraveling the antitrypanosomal mechanism of benznidazole and related 2-nitroimidazoles: From prodrug activation to DNA damage.

Molecular microbiology·2021

Same author

Evaluation of trypanocidal properties of ferrocenyl and cyrhetrenyl N-acylhydrazones with pendant 5-nitrofuryl group.

Journal of inorganic biochemistry·2021

Same author

Challenges in Chagas Disease Drug Development.

Molecules (Basel, Switzerland)·2020

Search research articles

Related Experiment Video

Updated: Mar 29, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

Evaluating 5-Nitrothiazoles as Trypanocidal Agents.

Ivan P O'Shea¹, Mohammed Shahed¹, Benjamín Aguilera-Venegas²

¹School of Biological and Chemical Sciences, Queen Mary University of London, London, United Kingdom.

Antimicrobial Agents and Chemotherapy

|November 25, 2015

Summary

New 5-nitrothiazole compounds show potent anti-parasitic activity against Trypanosoma brucei, the cause of sleeping sickness. This drug class may offer a promising new treatment for human African trypanosomiasis.

More Related Videos

An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity

An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity

Published on: November 2, 2016

Author Spotlight: A New and Efficient Method for Comprehensive Metabolite Cytotoxicity Assessment of Triazole Pesticides in Plants

Author Spotlight: A New and Efficient Method for Comprehensive Metabolite Cytotoxicity Assessment of Triazole Pesticides in Plants

Published on: December 22, 2023

Related Experiment Videos

Last Updated: Mar 29, 2026

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase

Published on: November 5, 2021

An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity

An Efficient Method for the Synthesis of Peptoids with Mixed Lysine-type/Arginine-type Monomers and Evaluation of Their Anti-leishmanial Activity

Published on: November 2, 2016

Author Spotlight: A New and Efficient Method for Comprehensive Metabolite Cytotoxicity Assessment of Triazole Pesticides in Plants

Author Spotlight: A New and Efficient Method for Comprehensive Metabolite Cytotoxicity Assessment of Triazole Pesticides in Plants

Published on: December 22, 2023

Area of Science:

Medicinal Chemistry
Parasitology
Drug Discovery

Background:

Human African trypanosomiasis is a neglected tropical disease caused by Trypanosoma brucei.
Current treatments have limitations, necessitating the development of new therapeutic agents.

Purpose of the Study:

To evaluate the growth-inhibitory properties of a 5-nitrothiazole series against Trypanosoma brucei.
To identify potent and selective antiparasitic compounds for potential therapeutic use.

Main Methods:

Screening of a 5-nitrothiazole chemical series for activity against Trypanosoma brucei.
Assessment of compound cytotoxicity against mammalian cells.
Investigating the mechanism of action, including the role of type I nitroreductase.

Main Results:

A subset of 5-nitrothiazole compounds exhibited significant growth inhibition of Trypanosoma brucei.
These potent compounds demonstrated minimal cytotoxicity to mammalian cells.
Antiparasitic activity was found to be dependent on the trypanosome's expression of type I nitroreductase.

Conclusions:

The 5-nitrothiazole class represents a promising new lead for treating human African trypanosomiasis.
Selective inhibition of Trypanosoma brucei by these compounds is linked to nitroreductase activity.
Further development of these nitroheterocyclic drugs could address unmet medical needs.